Source: European Biotechnology

Vicore Pharma received $9.6M in Post-IPO Equity Funding

Read full article »

Vicore Pharma's Competitors | Vicore Pharma's News | Vicore Pharma's Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

1-25

CEO

Ahmed Mousa

CEO Approval Rating

82/100

Vicore is a Sweden-based clinical-stage pharmaceutical company that researches and develops novel therapeutics for the treatment of rare lung diseases.